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OBJECTIVES: Recent guidelines recommend that all cirrhotic patients should undergo endoscopic screening for
esophageal varices. That identifying cirrhotic patients with esophageal varices by noninvasive predictors would
allow for the restriction of the performance of endoscopy to patients with a high risk of having varices. This study
aimed to develop a decision model based on classification and regression tree analysis for the prediction of large
esophageal varices in cirrhotic patients.
METHODS: 309 cirrhotic patients (training sample, 187 patients; test sample 122 patients) were included. Within the
training sample, the classification and regression tree analysis was used to identify predictors and prediction model
of large esophageal varices. The prediction model was then further evaluated in the test sample and different Child-
Pugh classes.
RESULTS: The prevalence of large esophageal varices in cirrhotic patients was 50.8%. A tree model that was
consisted of spleen width, portal vein diameter and prothrombin time was developed by classification and
regression tree analysis achieved a diagnostic accuracy of 84% for prediction of large esophageal varices. When
reconstructed into two groups, the rate of varices was 83.2% for high-risk group and 15.2% for low-risk group.
Accuracy of the tree model was maintained in the test sample and different Child-Pugh classes.
CONCLUSIONS: A decision tree model that consists of spleen width, portal vein diameter and prothrombin time may
be useful for prediction of large esophageal varices in cirrhotic patients.
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INTRODUCTION
Variceal hemorrhage is a leading cause of morbidity and
mortality in cirrhosis.1 Primary prophylaxis with nonselec-
tive beta-blockers and endoscopic band ligation may reduce
the risk of variceal bleeding.2 Therefore, it is recommended
that patients with cirrhosis should undergo endoscopic
screening for esophageal varices (EV) at the time of diag-
nosis.3 If no varices are observed on initial endoscopy
in patients with compensated cirrhosis, endoscopy should
be repeated in 3 years; in decompensated cirrhotic patients,
it should be repeated annually.3 As a result of the cost and
invasive nature of endoscopic screening, there is interest
in developing a noninvasive predictor of the presence
and development of varices that would decrease the
number of endoscopies performed.1 Predicting the presence
of esophageal varices by non-invasive means would restrict
the performance of endoscopy to those patients with a high
probability of having varices. A number of studies have
addressed the issue of identifying patients with varices by
non-invasive means with the aim of avoiding endoscopy in
those at low risk of having varices.4-7 Several prediction
models such as combination of platelet count and Child-
Pugh class,8 platelet count and splenomegaly,9,10 and spleen
width and portal vein diameter11 were also investigated.
However, different studies performed in cirrhotic patients
have yielded different results.1,5,12 This may be owing to
differences in the population selection or the proportion of
different etiologies of cirrhosis.
The classification and regression tree (CART) analysis is a
nonparametric method based on binary recursive partition-
ing of data. The results of CART analysis are presented as a
decision tree that is intuitive and facilitates the allocation of
patients into subgroups by following the flow-chart form
that is simple to interpret and may be applied at the
bedside. CART has been shown to be competitive with other
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traditional statistical techniques such as logistic regression
analysis.13 To the best of our knowledge, CART analysis has
not been used up until now in the assessment of predictors
of large esophageal varices (LEV) in cirrhotic patients
without a history of variceal bleeding. It is well known that
LEV have a significantly higher risk of bleeding than small
varices.14 It is presumed that a certain combination of
factors yields a more effective prediction of outcome than
when factors are used singly. The aim of the present study
was to use CART analysis to develop a simple tree model
for predicting the presence of LEV in cirrhotic patients.
MATERIALS AND METHODS
Cirrhotic patients who presented at our hospital between
January 2006 and January 2009 were eligible, irrespective of
the etiology and stage of live disease. Exclusion criteria
included: previous variceal bleeding; previous endoscopic
sclerosis or band ligation of EV; previous surgery for portal
hypertension or transjugular intrahepatic porto-systemic
stent shunt placement. None of the patients were treated
with b-blockers or diuretics. Hepatocellular carcinoma,
spontaneous bacterial peritonitis or portal vein thrombosis
were excluded from the study.
Age, gender and biochemical parameters were recorded.
All patients underwent ultrasonographic examination of the
upper abdomen, including measurement of spleen width
and portal vein diameter.15 The presence and degree of
ascites and encephalopathy were assessed according to
Child-Pugh criteria.16 The presence and size of EV were
determined and recorded for each patient. The size of
varices was subdivided into two classes – small and large –
according to the criteria proposed at the Baveno I Consensus
Conference.17 Diuretics therapy was not commenced before
endoscopy and ultrasonography was performed. The study
protocol was approved by the Ethics Committee of the First
Affiliated Hospital of Wenzhou Medical College.
A Shapiro-Wilk test was used to evaluate whether the
continuous data was normal distribution. According to the
results of Shapiro-Wilk test, continuous values were
expressed as mean¡ SD or median and interquartile range
and compared using Student’s t-test or the Mann-Whitney
non-parametric test. Categorical values were described by
count and proportions and compared by the chi-square test.
Study participants were randomly assigned to the training
and test sample (training sample, 60%; test sample, 40%)
using a computer random number generator.
The CART analysis was carried out on the training
sample in order to establish a simple tree model for
prediction of LEV. Impurity function (Gini criterion func-
tion) was used for splitting.18 By stopping rule, maximum
tree depth is 3 levels, and the case number of parent node
and child node is 25 and 1 each. Cut-off points for
continuous and ordinal variables were generated automa-
tically by the model based on statistical cost assumptions.13
Overall sensitivity, specificity, negative predictive value,
positive predictive value and diagnostic accuracy of the tree
model generated by CART analysis in the training sample
were validated in the test sample.
Differences were considered to be statistically significant
if the two-tailed p value was ,0.05.
RESULTS
Baseline Characteristics in the Entire Study
Population
A total of 309 patients (training sample, 187 patients; test
sample, 122 patients) were included in the study (Figure 1).
Of those, 207(67%) were male and their median age was
54(range: 45-61) years. The demographic and clinical
Figure 1 - Flow diagram of patients included in the study.
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characteristics of the patients are presented in Table 1. In all
the patients, the most common cause of cirrhosis was
hepatitis B virus (56%). The majority of the patients were
Child-Pugh class A (37.9%) and B (41.7%). Ascites was
found in 31.4% of the patients by ultrasonography and
clinical examination. EV were present in 199 patients
(64.4%), and LEV in 157 patients (50.8%).
Univariate analysis revealed that Gamma-glutamyltrans-
ferase (c- GT), prothrombin time, platelet count, ascites,
portal vein diameter and spleen width were significantly
associated with the presence of LEV. Results are summa-
rized in Table 2.
The CART Analysis on the Training Sample
The CART analysis was carried out on the training set of
187 patients using the same variables as univariate analysis.
Figure 2 shows the resulting decision tree. The CART
analysis automatically selected three predictive variables to
produce a total of four terminal nodes. All three factors
selected as significant variables in the CART analysis were
also significantly associated with LEV by univariate analysis
(Table 2). The cut-off values were 44.5 mm, 11.75 mm and
17.05s for spleen width, portal vein diameter and pro-
thrombin time in the model, respectively. The four terminal
nodes were reconstructed into two groups according to the
possibility of the presence of LEV (P,0.001): a low-risk
group consisted of node 3 (spleen width#44.5 mm,
portal vein diameter#11.75 mm) and node 5 (spleen
width#44.5 mm, portal vein diameter.11.75 mm, pro-
thrombin time#17.05s), whose possibility of presence of
LEV was 15.2% (14/92); a high-risk group consisted of
node 2 (spleen width.44.5 mm) and node 6 (spleen
width#44.5 mm, portal vein diameter.11.75 mm, and
prothrombin time.17.05s), whose possibility of presence
of LEV was 83.2% (79/95).
Diagnostic values of various predictors in the tree model
are shown in Table 3. With a combination of three variables
together, sequentially, the tree model yielded a diagnostic
accuracy of 84.0%.
Validation of the CART Analysis on the Test Sample
CART analysis was carried out on the randomly selected
test sample (n = 122; Figure 3). The tree model achieved a
sensitivity and specificity of 87.5 % and 81%, respectively.
Assuming LEV prevalence of 52.5% in this population, the
positive and negative predictive values from the test sample
were 83.6% and 85.5%, respectively. The percentage of
patients correctly classified was 84.4%. As shown in Figure 4,
2 groups of patients divided by CART analysis still had
similar low (8/55, 14.5%) and high (56/67, 83.4%) prob-
ability of presence of LEV(P,0.001).
Validation According to Child-Pugh Class in the
Entire Study Population
Table 4 shows the diagnostic performance of the tree
model in the various Child-Pugh classes. The diagnostic
accuracy of the tree model was 84.6% in Child-Pugh class A
Table 1 - Demographic and clinical characteristics of 309
patients.
Variable Value
Age (yr) 54(45-61)*
Male (%) 67
Cause of cirrhosis
Hepatitis B 173(56)
Hepatitis B/alcohol 54(17.5)
Alcohol 67(21.7)
Other 15(4.8)
Child–Pugh score 7(6-9)*
Child–Pugh A/B/C (%) 37.9/41.7/20.4
Total Bilirubin (mmol/L) 28(19-44)*
Albumin (g/L) 31.7(27.4-36.2)*
ALT (IU/L) 41(31-66)*
Prothrombin time (s) 16.9(15.3-18.9)*
Platelets (109/L) 59(42-84)*
Portal vein diameter (mm) 11.9¡1.9{
Spleen width (mm) 44(40-53)*
EV none/small/large (%) 33.6/13.6/50.8
*Data are shown as median and interquartile range;
{Data are shown as mean ¡ SD
Table 2 - Univariate analysis of predictive factors of large esophageal varices in 309 patients.
Variable Patients with no or small varices N=152 Patients with large varices N=157 P
Age (yr) 54.5(44-61.5) 54(47-61) 0.89*
Male (%) 67.8 66.2 0.78{
Child–Pugh score 7(6-9) 8(6-9) 0.06*
Total Bilirubin (mmol/L) 26.5(17-41.5) 30(20-44) 0.12*
Total protein (g/L) 65(60-68.9) 64(59.7-69.1) 0.12*
Albumin (g/L) 32.6(26.8-36.8) 30.8(27.5-35.8) 0.33*
ALT (U/L) 41(31-73) 42(30-61) 0.50*
AST (U/L) 63(38-99) 64(44-86) 0.87*
Alkaline phosphatase (U/L) 112(78-167) 105(80-138) 0.22*
c- GT (U/L) 80(42-179.5) 64(36-132) 0.047*
Prothrombin time(s) 16.6(15-18.9) 17.1(15.7-18.9) 0.04*
Prothrombin activity (%) 64.3(53-79.5) 62(52-71) 0.05*
Platelets (109/L) 75(51.5-110) 49(36-65) ,0.001*
Ascites (N) 0.028{
None 115 97
Non-tense 17 31
Tense 20 29
Portal vein diameter (mm) 10.9¡1.7 12.9¡1.6 ,0.001&
Spleen width (mm) 41(40-43) 50(44-59) ,0.001*
*Mann-Whitney non-parametric test; {chi-square test; & Student’s t-test; ALT = alanine aminotransferase; AST = aspartate aminotransferase; c- GT =
Gamma-glutamyltransferase
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patients, 83.7% in Child-Pugh class B patients and 85.7% in
Child-Pugh class C patients.
DISCUSSION
Splenomegaly is recognized as one of the diagnostic signs
of cirrhosis and portal hypertension. Several studies have
reported that splenomegaly could be a good predictor of
LEV for cirrhotic patients.9,10,14 Our previous study showed
that spleen width measured by ultrasonography was an
independent predictor for the presence of EV,11 whereas the
relationship between spleen width and LEV has not been
investigated before. The present study indicated that spleen
width was the strongest factor for prediction of LEV. Using
a cut-off of 44.5 mm, spleen width achieved a sensitivity of
73.1% and specificity of 85.1%.
EV is the direct consequence of the spontaneous formation
of collateral vessels between the portal vein and esophageal
veins via the left gastric or short gastric veins. Therefore, the
presence or absence of EV can reflect severity of portal
hypertension. It had been reported that portal vein diameter
was an independent predictor for the presence of varices.5,19
However, few data are available about the relationship
between portal vein diameter and LEV. Our data showed
that portal vein diameter was the second most important
predictor for LEV in patients with a spleen width of
#44.5 mm. However, it did not play an important role in
predicting LEV in patients with spleen width of . 44.5 mm.
When the spleen width and portal vein diameter were
combined sequentially (Table 3), 81.8% of patients could be
correctly classified. However, the specificity (73.4%) and
positive predictive value (77.1%) were low, which means that
Figure 2 - A tree model for prediction of large esophageal varices (LEV) generated by classification and regression tree (CART) analysis
in the training set of 187 patients.
Table 3 - Diagnostic values of various predictors in the
tree model.
Variable Se (%) Sp (%) PPV (%) NPV (%) DA (%)
SW (.44.5 mm) 73.1 85.1 82.9 76.2 79.1
PVD (.11.75 mm) 64.0 86.3 59.3 88.5 80.95
PT (.17.05s) 68.8 81.8 84.6 64.3 74.1
SW, PVD combined 90.3 73.4 77.1 88.5 81.8
SW, PVD, PT
combined
84.9 82.98 83.2 84.8 84.0
SW= spleen width; PVD=portal vein diameter; PT=prothrombin time;
Se = sensitivity; Sp = specificity; PPV=positive predictive value; NPV=
negative predictive value; DA=diagnostic accuracy
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some of the patients with splenomegaly and dilated portal
vein may not have LEV. One possible explanation for this
result could be the development of spontaneous intra-
abdominal shunts (such as paraumbilical vein or another
shunts) that decrease the blood flow of varices while
maintaining congestive splenomegaly and dilated portal vein.
Prothrombin time is considered a marker of hepatocel-
lular dysfunction. As portal hypertension is a consequence,
in part, of the generalized vasodilation and the hyperdy-
namic splanchnic and systemic circulatory state, the degree
of hepatic function likely affects the development of por-
tal hypertension via humoral factors and, therefore, the
Figure 3 - Validation in the test set of the tree model obtained by classification and regression tree (CART) analysis from the training
set.
Figure 4 - Patients stratified by the tree model in training sample
and test sample.
Table 4 - Diagnostic values of the tree model according to
Child-Pugh class.
Child-Pugh Se (%) Sp (%) PPV (%) NPV (%) DA (%)
Class A 82.4 86.4 82.4 86.4 84.6
Class B 92.5 74.2 79.5 90.2 83.7
Class C 92.3 75.0 85.7 85.7 85.7
Se= sensitivity; Sp= specificity; PPV=positive predictive value; NPV=
negative predictive value; DA=diagnostic accuracy
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development of varices. Moreover, the degree of liver
fibrosis is related to liver function and fibrosis can directly
affect portal hypertension. It has been reported that serum
fibrosis markers can detect LEV with a high accuracy,20
though several studies showed prothrombin time was
associated with LEV on univariate analysis.4,14 Most studies
suggested that it was not a predictor for EV.4,14,21,22 Our
data indicated that prothrombin time could be a predicator
for LEV in selected patients with a spleen width of #44.5
mm and a portal vein diameter of .11.75 mm.
Not all factors selected as significant variables on the
univariate analysis were significantly associated with LEV
by CART analysis. As with c- GT and platelets, ascites were
not selected as significant variables in CART analysis. These
differences may indicate both the unique feature and the
limitations of the CART analysis.18 The unique feature is
that it could visualize significant predictors that specifically
apply to selected patients. The limitation is that not all
significant factors may be adopted in the decision tree as we
applied the rule to stop the CART procedure when the
sample size was below 25. This rule was applied to avoid
the generation of an over-fit model, which may lack
universality. Therefore, it is possible that platelet count or
ascites may become a significant variable in the CART
analysis if larger number of patients were included.
The tree model that consisted of more than three
parameters markedly improved sensitivity. It yielded a
sensitivity of 84.9 % which was higher that that of single
parameter and had an excellent specificity of 82.98% in the
training sample. Eight-four percent of patients were
correctly classified. Patients may be divided into a high-
risk group (83.2%) and low-risk group (15.2%) according to
the possibility of presence of LEV by CART analysis. This
suggests that patients with a spleen width .44.5 mm or
those with a spleen width of #44.5 mm, with a portal vein
diameter of .11.75 mm and a prothrombin time of .17.05s
would benefit from more frequent endoscopies. However,
endoscopies could be postponed in patients with a spleen
width of#44.5 mm, a portal vein diameter of#11.75 mm, or
in patients with a spleen width of #44.5 mm, a portal vein
diameter .11.75 mm and a prothrombin time of #17.05s.
Moreover, the tree model proved to be well calibrated
(predicted outcomes in the training sample were repro-
duced fairly in the test sample) and achieved a comparable
diagnostic accuracy of 84.4% in the test sample. Patients in
the test sample can also be organized into the high- (83.4%)
and low-risk (14.5%) groups (Figure 4). Furthermore, the
diagnostic accuracies of the tree model in the various Child-
Pugh classes were comparable. The intuitive nature of the
tree model allows an easy assessment of the risk of the
presence of LEV without the need for complex calculations.
Our study has several limitations. Data were collected
retrospectively, which may produce a population bias as
confirmed by the fact that the prevalence of LEV in our
series was higher that that in other studies,9,14 which may be
due, in part, to selected bias. In addition, the sample size of
this study was small. Therefore, a large prospective study is
mandatory.
CONCLUSIONS
We propose that a tree model based on CART analysis
may help clinicians identify patients who would most likely
benefit from referral for screening for LEV.
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